Welsh research could revolutionise lung cancer treatment
July 25th, 2011
ALMOST 2,000 patients have been recruited to a Welsh research trial which could cut the number of people dying from lung cancer.
The Fragmatic trial is the largest lung cancer trial in the world and could revolutionise the way the disease and other forms of cancer are treated.
It is studying whether a common, safe and cheap blood-thinning drug can prevent lung cancer from spreading throughout the body by preventing blood clots forming in the lungs.